Overexpression of RHAMM in prostate cancer cells increased phosphorylation of ROCKII and coflin with an accompanying increase in filopodia formation and EMT markers, vimentin and N-cadherin, and a decrease in E- cadherin (50). The gene discussed is HMMR; the disease is prostate carcinoma.